These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10831031)

  • 1. Effect of adjunctive treatment with serotonin-1A agonist tandospirone on memory functions in schizophrenia.
    Sumiyoshi T; Matsui M; Yamashita I; Nohara S; Uehara T; Kurachi M; Meltzer HY
    J Clin Psychopharmacol; 2000 Jun; 20(3):386-8. PubMed ID: 10831031
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment.
    Sumiyoshi T; Matsui M; Nohara S; Yamashita I; Kurachi M; Sumiyoshi C; Jayathilake K; Meltzer HY
    Am J Psychiatry; 2001 Oct; 158(10):1722-5. PubMed ID: 11579010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tandospirone, a promising alternative drug in the treatment of chorea.
    Maruka Y; Esumi E; Kojima S
    Intern Med; 2000 Dec; 39(12):1133. PubMed ID: 11197809
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of serotonin (5-HT)1A receptor agonist in a patient with psychogenic apneusis.
    Onizuka J; Murata T; Omori M; Wada Y
    J Clin Psychopharmacol; 2002 Jun; 22(3):334-7. PubMed ID: 12006907
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of serotonin 1A agonist tandospirone on depression symptoms in senile patients with dementia.
    Masuda Y; Akagawa Y; Hishikawa Y
    Hum Psychopharmacol; 2002 Jun; 17(4):191-3. PubMed ID: 12404687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin 1A receptors in memory function.
    Sumiyoshi T; Meltzer HY
    Am J Psychiatry; 2004 Aug; 161(8):1505; author reply 1505-6. PubMed ID: 15285993
    [No Abstract]   [Full Text] [Related]  

  • 7. The anxiolytic effects of the 5-hydroxytryptamine-1A agonist tandospirone before otolaryngologic surgery.
    Oshima T; Kasuya Y; Terazawa E; Nagase K; Saitoh Y; Dohi S
    Anesth Analg; 2001 Nov; 93(5):1214-6. PubMed ID: 11682400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of frozen gait by tandospirone, a serotonin 1A agonist, in a patient with pure akinesia developing resistance to L-threo-3,4-dihydroxyphenylserine.
    Miyata S; Hamamura T; Yoshinaga J; Nakamura Y; Imamura T; Hikiji A; Kuroda S
    Clin Neuropharmacol; 2001; 24(4):232-4. PubMed ID: 11479395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin receptor responsivity in schizophrenia.
    Kahn RS; Davidson M
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():47-51. PubMed ID: 7911140
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study.
    Sumiyoshi T; Park S; Jayathilake K; Roy A; Ertugrul A; Meltzer HY
    Schizophr Res; 2007 Sep; 95(1-3):158-68. PubMed ID: 17628435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia.
    Sumiyoshi T; Matsui M; Yamashita I; Nohara S; Kurachi M; Uehara T; Sumiyoshi S; Sumiyoshi C; Meltzer HY
    Biol Psychiatry; 2001 May; 49(10):861-8. PubMed ID: 11343682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of hippocampal 5-HT1A receptors on human explicit memory.
    Yasuno F; Suhara T; Nakayama T; Ichimiya T; Okubo Y; Takano A; Ando T; Inoue M; Maeda J; Suzuki K
    Am J Psychiatry; 2003 Feb; 160(2):334-40. PubMed ID: 12562581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Drug holiday' effects of tandospirone in a patient with Machado-Joseph disease.
    Takei A; Fukazawa T; Hamada T; Yabe I; Tashiro K
    Psychiatry Clin Neurosci; 2003 Dec; 57(6):607-8. PubMed ID: 14629711
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of tandospirone on "5-HT1A receptor-associated symptoms" in patients with Machado-Josephe disease: an open-label study.
    Takei A; Fukazawa T; Hamada T; Sohma H; Yabe I; Sasaki H; Tashiro K
    Clin Neuropharmacol; 2004; 27(1):9-13. PubMed ID: 15090930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preliminary open-label study of 5-HT1A partial agonist tandospirone for behavioural and psychological symptoms associated with dementia.
    Sato S; Mizukami K; Asada T
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):281-3. PubMed ID: 16817981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo drug action of tandospirone at 5-HT1A receptor examined using positron emission tomography and neuroendocrine response.
    Nakayama T; Suhara T; Okubo Y; Ichimiya T; Yasuno F; Maeda J; Takano A; Saijo T; Suzuki K
    Psychopharmacology (Berl); 2002 Dec; 165(1):37-42. PubMed ID: 12474116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective adjunctive use of tandospirone with perospirone for enhancing verbal memory and quality of life in schizophrenia.
    Sumiyoshi T; Higuchi Y; Matsui M; Arai H; Takamiya C; Meltzer HY; Kurachi M
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):965-7. PubMed ID: 17391821
    [No Abstract]   [Full Text] [Related]  

  • 18. Different effects of anxiolytic agents, diazepam and 5-HT(1A) agonist tandospirone, on hippocampal long-term potentiation in vivo.
    Mori K; Togashi H; Kojima T; Matsumoto M; Ohashi S; Ueno K; Yoshioka M
    Pharmacol Biochem Behav; 2001; 69(3-4):367-72. PubMed ID: 11509193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paroxetine-induced bruxism effectively treated with tandospirone.
    Kishi Y
    J Neuropsychiatry Clin Neurosci; 2007; 19(1):90-1. PubMed ID: 17308240
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of serotonin 1A agonist on acute spinal cord injury.
    Saruhashi Y; Matsusue Y; Hukuda S
    Spinal Cord; 2002 Oct; 40(10):519-23. PubMed ID: 12235534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.